Lamotrigine is a substrate for OCT1 in brain endothelial cells

Area of Science:

• Neuroscience
• Pharmacology
• Cell Biology

Background:

• The transport mechanisms of lamotrigine across the blood-brain barrier (BBB) are not well understood.
• Lamotrigine's physicochemical properties suggest challenges for brain delivery, yet it is effectively utilized.
• Investigating lamotrigine transport is crucial for understanding its efficacy and potential drug interactions.

Purpose of the Study:

• To investigate the in vitro transport of lamotrigine across a blood-brain barrier model.
• To identify specific drug transporters involved in lamotrigine uptake.
• To explore the interaction between lamotrigine and quetiapine concerning transporter activity.

Main Methods:

• Utilized an in vitro model of the human blood-brain barrier using hCMEC/D3 cells.
• Assessed lamotrigine uptake kinetics and its interaction with drug transporters.
• Employed transporter inhibitors and validated findings in cells overexpressing organic cation transporter 1 (OCT1).

Main Results:

• Lamotrigine uptake into brain endothelial cells is an active, saturable process mediated by OCT1.
• OCT1 mRNA and protein expression confirmed in the BBB model.
• Quetiapine was identified as a potent inhibitor of OCT1-mediated lamotrigine transport.

Conclusions:

• This study identifies organic cation transporter 1 (OCT1) as a key transporter for lamotrigine at the blood-brain barrier.
• The findings reveal a potential mechanism for pharmacokinetic drug-drug interactions between lamotrigine and quetiapine.
• Further research is needed to clarify the clinical implications for lamotrigine efficacy and drug interactions.